Director/PDMR Shareholding
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
(the "Company")
The Company was notified on 12 January 2022 that Ms Kate Cornish-Bowden, a Non-Executive Director of the Company, purchased 1,500 Ordinary 25p shares in the capital of the Company at a price of 684.485 pence per Ordinary share. As a result of this purchase, Ms Kate Cornish-Bowden aggregate holding of shares in the Company is 9.500 Ordinary shares, representing 0.02% of the Company's issued share capital.
Notification of dealing form
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Kate Cornish-Bowden | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Director | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | International Biotechnology Trust plc | |
b) | LEI | 213800N1QUJ744P76D11 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Ordinary shares | |
Identification code | GB0004559349 | ||
b) | Nature of the transaction | Share purchase | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
684.485p | 1,500 | ||
d) | Aggregated information
| Aggregated price | Aggregated volume |
N/A | N/A | ||
e) | Date of the transaction | 12 January 2022 | |
f) | Place of the transaction | London Stock Exchange (XLON) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.